Education
About Us
Working with TipRanks
Follow Us
Arecor Therapeutics PLC (GB:AREC)
:AREC
RESEARCH TOOLSreports
AREC Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.35p - 1.15p
Previous CloseN/A
Volume5.49K
Average Volume (3M)21.38K
Market Cap
£16.99M
Enterprise Value63.77M
Total Cash (Recent Filing)£3.26M
Total Debt (Recent Filing)£232.00K
Price to Earnings (P/E)―
Beta0.51
Next Earnings
Sep 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding37,756,600
10 Day Avg. Volume31,673
30 Day Avg. Volume21,379
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)15.89
Price to Sales (P/S)0.00
P/FCF Ratio-25.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Arecor Therapeutics PLC News
PremiumCompany Announcements
Arecor Therapeutics Grants New Share Options to Drive Growth
PremiumCompany Announcements
Arecor Therapeutics Passes All AGM Resolutions, Strengthening Governance
PremiumCompany Announcements
Arecor Therapeutics Announces Board Change with Dr. Alan Smith’s Retirement
PremiumCompany Announcements
Arecor Executives Show Confidence with Share Purchases
PremiumCompany Announcements
Arecor Partners with Skye Bioscience to Enhance Obesity Treatment
PremiumCompany Announcements
Arecor Chair Increases Stake with Share Purchase
PremiumCompany Announcements
Arecor Therapeutics Releases 2024 Annual Report and Announces AGMPremiumCompany Announcements
Arecor Therapeutics to Present Annual Results on Investor PlatformOptions Prices
Currently, No data available
---
Ownership Overview
5.27% Insiders
―
Mutual Funds
― Other Institutional Investors
94.73% Public Companies and
Individual Investors
AREC FAQ
What was Arecor Therapeutics PLC’s price range in the past 12 months?
Arecor Therapeutics PLC lowest share price was 0.35p and its highest was 1.15p in the past 12 months.
What is Arecor Therapeutics PLC’s market cap?
Arecor Therapeutics PLC’s market cap is £16.99M.
When is Arecor Therapeutics PLC’s upcoming earnings report date?
Arecor Therapeutics PLC’s upcoming earnings report date is Sep 18, 2025 which is in 71 days.
How were Arecor Therapeutics PLC’s earnings last quarter?
Arecor Therapeutics PLC released its earnings results on Apr 22, 2025. The company reported -0.155p earnings per share for the quarter, missing the consensus estimate of N/A by -0.155p.
Is Arecor Therapeutics PLC overvalued?
According to Wall Street analysts Arecor Therapeutics PLC’s price is currently Overvalued.
Does Arecor Therapeutics PLC pay dividends?
Arecor Therapeutics PLC does not currently pay dividends.
What is Arecor Therapeutics PLC’s EPS estimate?
Arecor Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arecor Therapeutics PLC have?
Arecor Therapeutics PLC has 37,756,600 shares outstanding.
What happened to Arecor Therapeutics PLC’s price movement after its last earnings report?
Arecor Therapeutics PLC reported an EPS of -0.155p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Arecor Therapeutics PLC?
Currently, no hedge funds are holding shares in GB:AREC
Company Description
Arecor Therapeutics PLC
Arecor Therapeutics PLC (AREC) is a biopharmaceutical company specializing in the development and commercialization of innovative medicines aimed at improving patient care and outcomes. The company operates within the pharmaceutical and biotechnology sectors, focusing on leveraging its proprietary formulation technology platform, Arestat™, to enhance the efficacy, safety, and stability of existing therapeutic products. Arecor's core offerings include proprietary products, partnered specialty medicines, and formulations for medicines in partnerships with leading pharmaceutical and biotechnology companies.